SeekingAlpha · Aug 20, 2026
GOF And BCAT Have Gone In Opposite Directions. Has Emotion Taken Over The Trade?
A year ago, the Guggenheim Strategic Opportunity fund (GOF) was on top of the CEF world, trading at a 30% market price premium over its NAV.
NYSE · BCAT
Financial Services · Asset Management
$16.00
Up+$0.11 (+0.69%)
Updated Aug 30, 2026, 1:33 PM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
BCAT closed at $16.00 after 20 trading sessions, up 0.88% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $15.89 | $16.00 | $15.83 | $16.00 | 436.69K |
| Aug 27, 2026 | $15.78 | $15.91 | $15.78 | $15.89 | 427K |
| Aug 26, 2026 | $15.85 | $15.89 | $15.78 | $15.79 | 440.76K |
| Aug 25, 2026 | $15.77 | $15.90 | $15.77 | $15.88 | 331.92K |
| Aug 24, 2026 | $15.90 | $15.918 | $15.745 | $15.77 | 544.46K |
| Aug 21, 2026 | $15.82 | $16.025 | $15.77 | $15.90 | 884.18K |
| Aug 20, 2026 | $15.86 | $15.86 | $15.735 | $15.74 | 521.68K |
| Aug 19, 2026 | $15.86 | $15.948 | $15.80 | $15.90 | 404.7K |
| Aug 18, 2026 | $15.68 | $15.78 | $15.65 | $15.76 | 557.71K |
| Aug 17, 2026 | $15.81 | $15.90 | $15.7117 | $15.72 | 945.15K |
| Aug 14, 2026 | $16.00 | $16.036 | $15.845 | $15.86 | 561.18K |
| Aug 13, 2026 | $16.11 | $16.20 | $16.02 | $16.19 | 939.93K |
| Aug 12, 2026 | $16.13 | $16.1671 | $16.00 | $16.05 | 838.3K |
| Aug 11, 2026 | $16.11 | $16.198 | $16.05 | $16.11 | 736.45K |
| Aug 10, 2026 | $16.03 | $16.13 | $16.02 | $16.08 | 569.24K |
| Aug 7, 2026 | $16.00 | $16.08 | $15.98 | $16.04 | 514.01K |
| Aug 6, 2026 | $15.90 | $16.0303 | $15.90 | $15.96 | 421.09K |
| Aug 5, 2026 | $16.03 | $16.10 | $15.87 | $15.87 | 603.31K |
| Aug 4, 2026 | $15.88 | $16.07 | $15.8673 | $16.03 | 774.48K |
| Aug 3, 2026 | $15.80 | $15.92 | $15.77 | $15.86 | 742.11K |
The latest Smart Investors Daily articles mentioning BCAT.
BCAT research
Company profile and research snapshot.
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Aug 20, 2026
A year ago, the Guggenheim Strategic Opportunity fund (GOF) was on top of the CEF world, trading at a 30% market price premium over its NAV.
SeekingAlpha · Aug 3, 2026
BCAT CEF analysis: tech rally supports yield, but ROC-heavy payouts risk NAV erosion. Learn why itâs a tactical hold, not core.
SeekingAlpha · Feb 26, 2026
businesswire.com · Nov 28, 2025
NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BCAT.